BR0112296A - Composição consistindo de ou contendo pelo menos um soro de leite dissimilado - Google Patents

Composição consistindo de ou contendo pelo menos um soro de leite dissimilado

Info

Publication number
BR0112296A
BR0112296A BR0112296-7A BR0112296A BR0112296A BR 0112296 A BR0112296 A BR 0112296A BR 0112296 A BR0112296 A BR 0112296A BR 0112296 A BR0112296 A BR 0112296A
Authority
BR
Brazil
Prior art keywords
composition consisting
dissimilated
whey
tolerance
human
Prior art date
Application number
BR0112296-7A
Other languages
English (en)
Inventor
Ulrich Leithe
Adrianus Mattheus Ma Zijerveld
Original Assignee
Sericausa B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sericausa B V filed Critical Sericausa B V
Publication of BR0112296A publication Critical patent/BR0112296A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçãO CONSISTINDO DE OU CONTENDO PELO MENOS UM SORO DE LEITE DISSIMILADO". Onde o presente invento descreve o uso de uma composição consistindo de ou contendo pelo menos um soro de leite dissimilado para melhorar a tolerância do organismo humano ou animal.
BR0112296-7A 2000-06-28 2001-06-25 Composição consistindo de ou contendo pelo menos um soro de leite dissimilado BR0112296A (pt)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
DE10031504 2000-06-28
DE10031505 2000-06-28
DE10031506 2000-06-28
DE10031507 2000-06-28
DE10032243 2000-07-03
DE10033560 2000-07-11
DE10033558 2000-07-11
DE10033559 2000-07-11
DE10107859 2001-02-20
PCT/EP2001/007202 WO2002000231A1 (de) 2000-06-28 2001-06-25 Verwendung einer zubereitung aus oder mit einem gehalt an mindestens einem dissimilierten milchserum

Publications (1)

Publication Number Publication Date
BR0112296A true BR0112296A (pt) 2003-06-24

Family

ID=27575990

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112296-7A BR0112296A (pt) 2000-06-28 2001-06-25 Composição consistindo de ou contendo pelo menos um soro de leite dissimilado

Country Status (11)

Country Link
US (1) US20030108617A1 (pt)
EP (1) EP1296692B1 (pt)
JP (1) JP2004501199A (pt)
KR (1) KR20030024715A (pt)
AT (1) ATE323502T1 (pt)
AU (1) AU2001281880A1 (pt)
BR (1) BR0112296A (pt)
CA (1) CA2412227A1 (pt)
DE (1) DE50109557D1 (pt)
MX (1) MXPA02012857A (pt)
WO (1) WO2002000231A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012319A1 (it) * 2001-11-06 2003-05-06 Mario Baraldi Uso del siero di latte contenente sostanze ad attivita' benzodiazepino-simile
WO2004112773A1 (fr) * 2003-04-24 2004-12-29 Shin-Jen Shiao Compositions pharmaceutiques utilisees pour le traitement de maladie immune et amelioration
IL157814A (en) * 2003-09-08 2007-12-03 Lev Bar Ltd Cosmetic composition comprising camel milk or components thereof
WO2006095764A1 (ja) * 2005-03-09 2006-09-14 Calpis Co., Ltd. 皮膚における紫外線感受性抑制剤及び機能性飲食品
WO2006137513A1 (ja) * 2005-06-24 2006-12-28 Calpis Co., Ltd. 表皮細胞分化及び角化促進剤、並びに表皮角化促進用機能性飲食品
EA018687B1 (ru) * 2005-11-28 2013-09-30 Байомедикал Рисерч Груп Инк. Фракция гликолипидов ферментированных экстрактов биологического пищевого материала и фармацевтическая композиция, содержащая указанную фракцию
GB0605949D0 (en) * 2006-03-24 2006-05-03 Quest Int Serv Bv Milk product for skin treatment
KR100951040B1 (ko) 2007-03-30 2010-04-05 고려대학교 산학협력단 치즈부산물을 함유한 사료조성물을 이용하여 가금류의 알을 생산하는 방법 및 상기 방법으로 생산된 알
WO2012004585A1 (en) * 2010-07-09 2012-01-12 Abdulla Badawy Ingestible formulation comprising glycomacropeptide and at least one of tryptophan, tyrosine and phenylalanine and uses thereof
SG11201509599QA (en) * 2013-07-05 2016-02-26 Yakult Honsha Kk Pentosidine production inhibitor
KR102026366B1 (ko) * 2018-05-11 2019-09-27 주식회사 네이처인랩 복합 프로바이오틱스의 유청 발효물을 포함하는 화장료 조성물, 이의 제조방법 및 이를 포함하는 기능성 화장품

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840670A (en) * 1972-03-01 1974-10-08 Fermented Prod Inc Condensed fermented whey animal feed product and method
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4897265A (en) * 1983-10-27 1990-01-30 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US5066491A (en) * 1985-04-15 1991-11-19 Protein Technology, Inc. Method of disease treatment utilizing an immunologically active whey fraction
US5017372A (en) * 1986-04-14 1991-05-21 Medicis Corporation Method of producing antibody-fortified dry whey
US5230902A (en) * 1988-04-29 1993-07-27 Immunotec Research Corporation Undenatured whey protein concentrate to improve active systemic humoral immune response
DE3827833C1 (pt) * 1988-08-17 1989-12-28 Horst 5419 Herschbach De Meinhardt
US5780451A (en) * 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
FR2718752B1 (fr) * 1994-04-15 1996-07-12 World Trust Investment Sa Préparations à base de lactosérum fermenté et leurs utilisations.
DE4427705A1 (de) * 1994-08-04 1996-02-08 Herbert Van Lier Pharmazeutisch wirksames, hautschonendes Milchserumbad
US5747031A (en) * 1995-10-05 1998-05-05 Immucell Corporation Process for isolating immunoglobulins in whey
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
WO1998031377A1 (en) * 1997-01-20 1998-07-23 Mohammed Essaidi Use of food products for protection against radicals
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition

Also Published As

Publication number Publication date
CA2412227A1 (en) 2002-12-11
US20030108617A1 (en) 2003-06-12
EP1296692B1 (de) 2006-04-19
DE50109557D1 (de) 2006-05-24
JP2004501199A (ja) 2004-01-15
EP1296692A1 (de) 2003-04-02
MXPA02012857A (es) 2004-07-30
KR20030024715A (ko) 2003-03-26
WO2002000231A1 (de) 2002-01-03
AU2001281880A1 (en) 2002-01-08
ATE323502T1 (de) 2006-05-15

Similar Documents

Publication Publication Date Title
ES2194344T3 (es) Bebida acida.
ES2162843T3 (es) Inhibidores de la proteina quinasa c.
BR0214705A (pt) Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit
BR9808348A (pt) Alimento medicinal para diabéticos
BR0112101A (pt) Interleucina 2 estabilizada
BR9913857A (pt) Formulações de proteìna
BR9902086A (pt) Formulações farmacêuticas.
PT1220620E (pt) Composicao contendo proteina caseina e proteina de soro de leite
EE05477B1 (et) Nahale aplitseeritavad vedelpreparaadid parasiitputukate t?rjumiseks loomadel
BR9906915A (pt) Composição que compreende mel, ou pelo menos um óleo essencial e/ou pelo menos um derivado de um óleo essencial.
BR0112296A (pt) Composição consistindo de ou contendo pelo menos um soro de leite dissimilado
BR0210481A (pt) Tablete de caldo de carne compacto
BR9916423A (pt) Formulação de baixo ponto de congelamento contendo fenol e/ou derivados de fenol
BRPI0414215A (pt) tienopirazóis
BR0115518A (pt) Kit de repinotan
BR0210543A (pt) Tablete macio de caldo de carne
BR9909357A (pt) Solução ou suspensão de mirtazapina em mistura com água, formulação farmacêutica compreendendo mirtazapina, e, uso de mirtazapina
ITMI20022394A1 (it) Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
BR0213536A (pt) Formulações de xarope de ribavirina
ATE383851T1 (de) Zusammensetzung mit cysteamin zur verbesserung der laktation von milchvieh
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
SE454397B (sv) Stabiliserad vattenbaserad antimikrobiell veteperoxidkomposition, forfarande for framstellning derav samt anvendning derav som antimikrobiell spendoppningskomposition for mjolkproducerande djur
PT1202956E (pt) Derivados terapeuticos e/ou nuricionalmente melhorados de ingredientes activos e composicoes de administracao oral contendo o mesmo
BR0210496A (pt) Caldo de carne em pó
ATE296039T1 (de) Zutat für säuglingsmilchnahrung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ,7A E 8A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009.